CoChat

Frequent Antibiotic Use and Second Breast Cancer Events

Open access
Wirtz, Heidi S., Buist, Diana S.M., Gralow, Julie R., Barlow, William E., Gray, Shelly, Chubak, Jessica, Yu, Onchee, Bowles, Erin J.A., Fujii, Monica, Boudreau, Denise M. · 2013 · Cancer Epidemiology, Biomarkers & Prevention
Cited by 40

The DOI matches its Crossref record.

Abstract

Background: Antibiotic use may be associated with higher breast cancer risk and breast cancer mortality, but no study has evaluated the relation between antibiotic use and second breast cancer events (SBCE). Methods: We conducted a retrospective cohort study among women ≥18 years, diagnosed with incident stage I/II breast cancer during 1990–2008. Antibiotic use and covariates were obtained from health plan administrative databases and medical record review. Frequent antibiotic use was defined as ≥4 antibiotic dispensings in any moving 12-month period after diagnosis. Our outcome was SBCE defined as recurrence or second primary breast cancer. We used multivariable Cox proportional hazards models to estimate HR and 95% confidence intervals (CI), accounting for competing risks. Results: A total of 4,216 women were followed for a median of 6.7 years. Forty percent were frequent antibiotic users and 558 (13%) had an SBCE. Results are suggestive of a modest increased risk of SBCE (HR, 1.15; 95% CI, 0.88–1.50) among frequent antibiotic users compared with nonusers. Any potential increased risk was not supported when we evaluated recent use and past use. We observed no dose–response trends for SBCE with increasing duration of antibiotic use nor did we find evidence for altered SBCE risk in the antibiotic classes studied. Conclusions: Frequent antibiotic use may be associated with modestly elevated risk of SBCEs, but the association was not significant. Impact: Additional investigation by antibiotic class and underlying indication are important next steps given the high prevalence of frequent antibiotic use and growing number of breast cancer survivors. Cancer Epidemiol Biomarkers Prev; 22(9); 1588–99. ©2013 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-13-0454

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 40

Metadata

Authors
Wirtz, H. S., Buist, D. S. M., Gralow, J. R., Barlow, W. E., Gray, S., Chubak, J., Yu, O., Bowles, E. J. A., Fujii, M., & Boudreau, D. M.
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2013-09-01
Volume
22
Issue
9
Pages
1588-1599
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
OpenAlex
W2143467618
Cited by
40
References
0
FWCI
1.95
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Frequent Antibiotic Use and Second Breast Cancer Events. https://app.cochat.ai/papers/10.1158/1055-9965.epi-13-0454
The paper
Wirtz, H. S., Buist, D. S. M., Gralow, J. R., Barlow, W. E., Gray, S., Chubak, J., Yu, O., Bowles, E. J. A., Fujii, M., & Boudreau, D. M. (2013). Frequent Antibiotic Use and Second Breast Cancer Events. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-13-0454

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.